Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor/G-CSF versus chemotherapy/G-CSF for autologous stem cell mobilization
2009-013798-16Phase 2Completed
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Start
- Jun 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of plerixafor and granulocyte colony-stimulating factor in lymphoma and multiple myeloma (MM) (2 arms), sponsored by Liverpool University Hospitals NHS Foundation Trust. Primary endpoint: Composite primary endpoint. Started Jun 2010; status: completed.
02
Drugs
plerixaforgranulocyte colony-stimulating factor
03
Conditions
lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on 2009-013798-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013798-16.